Glenmark Pharma is set to declare its results for the third quarter of financial year 2012-13 on Tuesday. Analysts on an average expect profit after tax to grow 4 times year-on-year to Rs 181 crore in the quarter due to EBITDA expansion and one off income.
first published: Jan 29, 2013 12:40 pm
A collection of the most-viewed Moneycontrol videos.
You are already a Moneycontrol Pro user.

